Page last updated: 2024-10-25

diazoxide and Neoplasm Metastasis, Unknown Primary

diazoxide has been researched along with Neoplasm Metastasis, Unknown Primary in 1 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Research Excerpts

ExcerptRelevanceReference
"A survey of UK patients receiving the drug diazoxide, revealed 40 patients with insulinoma on this treatment."7.69Diazoxide treatment for insulinoma: a national UK survey. ( Gill, GV; MacFarlane, IA; Rauf, O, 1997)
"A survey of UK patients receiving the drug diazoxide, revealed 40 patients with insulinoma on this treatment."3.69Diazoxide treatment for insulinoma: a national UK survey. ( Gill, GV; MacFarlane, IA; Rauf, O, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gill, GV1
Rauf, O1
MacFarlane, IA1

Other Studies

1 other study available for diazoxide and Neoplasm Metastasis, Unknown Primary

ArticleYear
Diazoxide treatment for insulinoma: a national UK survey.
    Postgraduate medical journal, 1997, Volume: 73, Issue:864

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Diazoxide; Female; Health Care Surveys; Hum

1997